Trial Profile
Effects of rituximab and tocilizumab therapy on B-cell subsets in patients with Rheumatoid Arthritis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jul 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 14 Jul 2015 New trial record